First Pacific Bancorp announced solid third quarter 2026 results, with total assets reaching $532 million, up $42 million from year-end 2025. Deposits increased to $449 million, and loans grew to $362 million, reflecting steady balance sheet expansion. The bank maintained excellent asset quality with minimal non-performing assets and a strong capital position, including a leverage ratio of 9.18%. Net income for the quarter was $478,000, slightly down from the previous year, while the bank emphasized conservative underwriting and plans to expand into Palm Desert, signaling confidence in regional growth opportunities.
First Pacific Bancorp's third quarter 2026 results provide context for financial sector performance. For readers following financial stocks, here is Pluang's market snapshot as of Oct 23, 2026 01:11 WIB: out of 142 priced US financial stocks, 78 rose and 64 fell. Notable movers include Blackstone Inc (BX) at USD 116.74 with a 6.54% increase and a Pluang order activity of 55% Sell / 45% Buy, Rocket Companies Inc. Class A (RKT) at USD 11.83 up 6.48% with 0% Sell / 100% Buy, and Nasdaq Inc (NDAQ) at USD 102.16 up 6.28% with 93% Sell / 7% Buy activity. Typical hold times on Pluang range from 1 to 127 days among these stocks.
Remittix is set to add 41 new fiat currencies to its PayFi ecosystem, enhancing crypto-to-bank and bank-to-crypto transactions globally ahead of its November 24 RTX launch. This expansion aims to support more international markets and users, includin...
ICEYE and Nokia have signed a Letter of Intent with Ukraine's Ministry of Defence to collaborate on building sovereign satellite communication capabilities. This partnership aims to enhance Ukraine's defense by providing secure, high-performance sate...
Dayton T. Brown, Inc. inaugurated its new 104,000-square-foot Test & Qualification Center in Huntsville, Alabama, enhancing its capacity to support aerospace, defense, and propulsion programs. The facility's strategic location near Huntsville's aeros...
A new study by The Grossman Group reveals that while 60% of chief communications officers (CCOs) have influence at the leadership level, their communications functions lack the necessary systems, skills, and AI capabilities to fully meet their mandat...
More than 200 companies are actively developing over 240 Alzheimer's disease therapies, with around 20 drugs in late-stage trials and many others in earlier phases. Key players include Eli Lilly, Biogen, Johnson & Johnson, and Eisai, focusing on inno...
